Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 β-lactamases at 2 hospitals in Taiwan

Lii Tzu Wu, Hwa Jen Wu, Jing Gung Chung, Yin Ching Chuang, Kuo Chen Cheng, Wen-Liang Yu

研究成果: 雜誌貢獻文章同行評審

21 引文 斯高帕斯(Scopus)

摘要

From February to June 2003, 111 clinical isolates of Proteus mirabilis were mainly isolated from patients with respiratory or urinary tract infections hospitalized at 3 district hospitals (A, B, C) in central Taiwan. Among them, 34 (30.6%) strains, isolated within 2 hospitals (A and B), exhibited nonsusceptibility to cefotaxime with significant reduction of MIC (≥3 log2 dilution) by the effect of clavulanic acid, which confirmed the phenotype of extended-spectrum β-lactamases (ESBLs). These ESBL producers were coresistant to gentamicin, isepamicin, and amikacin, but remained susceptible to ceftazidime (MIC, ≤0.5 μg/mL) and meropenem (MIC,
原文英語
頁(從 - 到)89-94
頁數6
期刊Diagnostic Microbiology and Infectious Disease
54
發行號2
DOIs
出版狀態已發佈 - 二月 2006

ASJC Scopus subject areas

  • 傳染性疾病
  • 免疫學和過敏
  • 病毒學
  • 寄生物學
  • 微生物學
  • 免疫學
  • 應用微生物與生物技術

指紋

深入研究「Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 β-lactamases at 2 hospitals in Taiwan」主題。共同形成了獨特的指紋。

引用此